Ewa Grudzien Nogalska

Ewa Grudzien Nogalska, Ph.D. has a wealth of experience in the field of RNA Science. Ewa began their career in 2006 as a Research Associate at LSU Health Shreveport, where they studied improper mammary epithelial cells differentiation and epithelial-to-mesenchymal transition caused by downregulation of RNA-binding protein CPEB1. Ewa was later promoted to Postdoctoral Fellow, where they developed new cap analogs that stabilized mRNA and increased translational efficiency in mammalian cells. In 2014, they moved to Rutgers University, where they held the roles of Research Associate (non-tenure track Faculty) and Postdoctoral Associate. Most recently, they joined Myeloid Therapeutics in 2022 as Senior Scientist, RNA Science.

Ewa Grudzien Nogalska, Ph.D. obtained their Doctor of Philosophy (PhD) in Biochemistry, Biophysics and Molecular Biology from the Department of Biophysics at Warsaw University, Warsaw, Poland from 2002 to 2006. Prior to that, they obtained their Master's degree in Organic Chemistry from the Department of Chemistry at Warsaw University from 1997 to 2002.